Myovant Sciences Ltd. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Myovant Sciences Ltd. reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $23.35 million for the 12-month period ending 2019-03-31, per its 10-K filed 2019-05-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2019-05-24
- Myovant Sciences Ltd. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-03-31 was $5.27M, a 44.23% decline year-over-year.
- Myovant Sciences Ltd. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-12-31 was $9.90M, a 57.97% increase year-over-year.
- Myovant Sciences Ltd. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-09-30 was $136.00K, a 95.82% decline year-over-year.
- Myovant Sciences Ltd. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-06-30 was $8.04M.
- Myovant Sciences Ltd. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $23.35M, a 27.68% increase from fiscal 2018.
- Myovant Sciences Ltd. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $18.29M, a 55.57% increase from fiscal 2017.
- Myovant Sciences Ltd. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $11.76M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | $5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-24 | $15.17M derived: sum of 2 quarters · filed 2019-05-24 | $15.31M derived: sum of 3 quarters · filed 2019-05-24 | $23.35M 10-K · filed 2019-05-24 | ||
| 2018-12-31 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | $10.04M derived: sum of 2 quarters · filed 2019-02-07 | $18.08M 10-Q · filed 2019-02-07 | $27.53M derived: sum of 4 quarters · filed 2019-05-24 | ||
| 2018-09-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $8.18M 10-Q · filed 2018-11-08 | $17.63M derived: sum of 3 quarters · filed 2019-05-24 | $23.89M derived: sum of 4 quarters · filed 2019-05-24 | ||
| 2018-06-30 | $8.04M 10-Q · filed 2018-08-07 | $17.49M derived: sum of 2 quarters · filed 2019-05-24 | $23.76M derived: sum of 3 quarters · filed 2019-05-24 | $27.01M derived: sum of 4 quarters · filed 2019-05-24 | ||
| 2018-03-31 | $9.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-24 | $15.72M derived: sum of 2 quarters · filed 2019-05-24 | $18.97M derived: sum of 3 quarters · filed 2019-05-24 | $18.29M 10-K · filed 2019-05-24 | ||
| 2017-12-31 | $6.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | $9.52M derived: sum of 2 quarters · filed 2019-02-07 | $8.84M 10-Q · filed 2019-02-07 | $17.68M derived: sum of 4 quarters · filed 2019-05-24 | ||
| 2017-09-30 | $3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $2.57M 10-Q · filed 2018-11-08 | $11.41M derived: sum of 3 quarters · filed 2019-05-24 | $13.28M derived: sum of 4 quarters · filed 2019-05-24 | ||
| 2017-06-30 | -$686.00K 10-Q · filed 2018-08-07 | $8.16M derived: sum of 2 quarters · filed 2019-05-24 | $10.03M derived: sum of 3 quarters · filed 2019-05-24 | $10.82M derived: sum of 4 quarters · filed 2019-05-24 | ||
| 2017-03-31 | $8.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-24 | $10.71M derived: sum of 2 quarters · filed 2019-05-24 | $11.51M derived: sum of 3 quarters · filed 2019-05-24 | $11.76M 10-K · filed 2019-05-24 | ||
| 2016-12-31 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-13 | $2.67M derived: sum of 2 quarters · filed 2018-02-13 | $2.91M 10-Q · filed 2018-02-13 | $3.46M 10-Q · filed 2017-02-13 | ||
| 2016-09-30 | $799.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-13 | $1.04M 10-Q · filed 2017-11-13 | $1.41M 10-Q · filed 2016-12-09 | |||
| 2016-06-30 | $244.00K 10-Q · filed 2017-08-10 |